Pharmadigm, Mipharm S.p.A. deal

Mipharm will develop in Europe Pharmadigm's PB005, an injectable dehydroepiandrosterone for the management of acute inflammation. Mipharm will make a $350,000 equity investment in Pharmadigm and fund ...